The bright and the dark sides of DNA repair in stem cells

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Frosina, Guido ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZD 7762; BEVACIZUMAB; CP 466722; PROTEIN SERINE THREONINE KINASE INHIBITOR; TEMOZOLOMIDE; TRANSFORMING GROWTH FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

APOPTOSIS; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER RESISTANCE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL RENEWAL; CELL TRANSFORMATION; CLINICAL TRIAL; DNA REPAIR; DNA STRAND BREAKAGE; DRUG PROTEIN BINDING; DRUG TARGETING; EMBRYONIC STEM CELL; GLIOBLASTOMA; HUMAN; MALIGNANT TRANSFORMATION; MESENCHYMAL STEM CELL; NONHUMAN; PROGNOSIS; REVIEW; SOMATIC MUTATION; STEM CELL; TREATMENT RESPONSE; TUMOR GROWTH; ANIMAL; BIOLOGICAL MODEL; CANCER STEM CELL; PHYSIOLOGY;

ANIMALS; DNA REPAIR; HUMANS; MODELS, BIOLOGICAL; NEOPLASTIC STEM CELLS; STEM CELLS;

EID: 77952469080     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/845396     Document Type: Review

References (115)

1. Hong Y., Cervantes R. B., Tichy E., Tischfield J. A., Stambrook P. J., Protecting genomic integrity in somatic cells and embryonic stem cells Mutation Research 2007 614 1-2 48 55
2. Tichy E. D., Stambrook P. J., DNA repair in murine embryonic stem cells and differentiated cells Experimental Cell Research 2008 314 9 1929 1936
3. Park Y., Gerson S. L., DNA repair defects in stem cell function and aging Annual Review of Medicine 2005 56 495 508
4. Lin Q., Donahue S. L., Ruley H. E., Genome maintenance and mutagenesis in embryonic stem cells Cell Cycle 2006 5 23 2710 2714
5. Maynard S., Swistowska A. M., Lee J. W., Human embryonic stem cells have enhanced repair of multiple forms of DNA damage Stem Cells 2008 26 9 2266 2274
6. Frosina G., DNA repair in normal and cancer stem cells, with special reference to the central nervous system Current Medicinal Chemistry 2009 16 7 854 866
7. Kenyon J., Gerson S. L., The role of DNA damage repair in aging of adult stem cells Nucleic Acids Research 2007 35 22 7557 7565
8. Warren L. A., Rossi D. J., Stem cells and aging in the hematopoietic system Mechanisms of Ageing and Development 2009 130 1-2 46 53
9. Galderisi U., Helmbold H., Squillaro T., In vitro senescence of rat mesenchymal stem cells is accompanied by downregulation of stemness-related and DNA damage repair genes Stem Cells and Development 2009 18 7 1033 1041
10. Saretzki G., Walter T., Atkinson S., Downregulation of multiple stress defense mechanisms during differentiation of human embryonic stem cells Stem Cells 2008 26 2 455 464
11. Banth J. P., Bauelos C. A., Klokov D., MacPhail S. M., Lansdorp P. M., Olive P. L., Explanation for excessive DNA single-strand breaks and endogenous repair foci in pluripotent mouse embryonic stem cells Experimental Cell Research 2009 315 8 1505 1520
12. Weinstock D. M., Jasin M., Alternative pathways for the repair of RAG-induced DNA breaks Molecular and Cellular Biology 2006 26 1 131 139
13. Saretzki G., Armstrong L., Leake A., Lako M., von Zglinicki T., Stress defense in murine embryonic stem cells is superior to that of various differentiated murine cells Stem Cells 2004 22 6 962 971
14. Roos W. P., Christmann M., Fraser S.T., Kaina B., Mouse embryonic stem cells are hypersensitive to apoptosis triggered by the DNA damage O6-methylguanine due to high E2F1 regulated mismatch repair Cell Death and Differentiation 2007 14 8 1422 1432
15. Casorelli I., Russo M. T., Bignami M., Role of mismatch repair and MGMT in response to anticancer therapies Anti-Cancer Agents in Medicinal Chemistry 2008 8 4 368 380
16. van der Wees C., Jansen J., Vrieling H., van der Laarse A., Van Zeeland A., Mullenders L., Nucleotide excision repair in differentiated cells Mutation Research 2007 614 1-2 16 23
17. de Waard H., Sonneveld E., de Wit J., Cell-type-specific consequences of nucleotide excision repair deficiencies: embryonic stem cells versus fibroblasts DNA Repair 2008 7 10 1659 1669
18. Sii-Felice K., Etienne O., Hoffschir F., Fanconi DNA repair pathway is required for survival and long-term maintenance of neural progenitors The EMBO Journal 2008 27 5 770 781
19. Sii-Felice K., Barroca V., Etienne O., Role of fanconi DNA repair pathway in neural stem cell homeostasis Cell Cycle 2008 7 13 1911 1915
20. Bracker T. U., Giebel B., Spanholtz J., Stringent regulation of DNA repair during human hematopoietic differentiation: a gene expression and functional analysis Stem Cells 2006 24 3 722 730
21. + hematopoietic stem and progenitor cells Mechanisms of Ageing and Development 2007 128 9 503 510
22. Nouspikel T. P., Hyka-Nouspikel N., Hanawalt P. C., Transcription domain-associated repair in human cells Molecular and Cellular Biology 2006 26 23 8722 8730
23. Nouspikel T., Hanawalt P. C., Terminally differentiated human neurons repair transcribed genes but display attenuated global DNA repair and modulation of repair gene expression Molecular and Cellular Biology 2000 20 5 1562 1570
24. Nouspikel T., DNA repair in differentiated cells: some new answers to old questions Neuroscience 2007 145 4 1213 1221
25. Casorelli I., Pelosi E., Biffoni M., Methylation damage response in hematopoietic progenitor cells DNA Repair 2007 6 8 1170 1178
26. Nowak E., Etienne O., Millet P., Radiation-induced H2AX phosphorylation and neural precursor apoptosis in the developing brain of mice Radiation Research 2006 165 2 155 164
27. Panagiotakos G., Alshamy G., Chan B., Long-term impact of radiation on the stem cell and oligodendrocyte precursors in the brain PLoS ONE 2007 2 7, article e588
28. Hildrestrand G. A., Diep D. B., Kunke D., The capacity to remove 8-oxoG is enhanced in newborn neural stem/progenitor cells and decreases in juvenile mice and upon cell differentiation DNA Repair 2007 6 6 723 732
29. Rolseth V., Rundn-Pran E., Luna L., McMurray C., Bjrs M., Ottersen O. P., Widespread distribution of DNA glycosylases removing oxidative DNA lesions in human and rodent brains DNA Repair 2008 7 9 1578 1588
30. Hildrestrand G. A., Neurauter C. G., Diep D. B., Expression patterns of Neil3 during embryonic brain development and neoplasia BMC Neuroscience 2009 10, article 45
31. Liang L., Deng L., Mendonca M. S., X-rays induce distinct patterns of somatic mutation in fetal versus adult hematopoietic cells DNA Repair 2007 6 9 1380 1385
32. Narciso L., Fortini P., Pajalunga D., Terminally differentiated muscle cells are defective in base excision DNA repair and hypersensitive to oxygen injury Proceedings of the National Academy of Sciences of the United States of America 2007 104 43 17010 17015
33. Backendorf C., de Wit J., Van Oosten M., Repair characteristics and differentiation propensity of long-term cultures of epidermal keratinocytes derived from normal and NER-deficient mice DNA Repair 2005 4 11 1325 1336
34. Gotherstrom C., West A., Liden J., Uzunel M., Lahesmaa R., Le Blanc K., Difference in gene expression between human fetal liver and adult bone marrow mesenchymal stem cells Haematologica 2005 90 8 1017 1026
35. Chen M.-F., Lin C.-T., Chen W.-C., The sensitivity of human mesenchymal stem cells to ionizing radiation International Journal of Radiation Oncology Biology Physics 2006 66 1 244 253
36. Serakinci N., Christensen R., Graakjaer J., Ectopically hTERT expressing adult human mesenchymal stem cells are less radiosensitive than their telomerase negative counterpart Experimental Cell Research 2007 313 5 1056 1067
37. Hanawalt P. C., Spivak G., Transcription-coupled DNA repair: two decades of progress and surprises Nature Reviews Molecular Cell Biology 2008 9 12 958 970
38. Hsu P.-H., Hanawalt P. C., Nouspikel T., Nucleotide excision repair phenotype of human acute myeloid leukemia cell lines at various stages of differentiation Mutation Research 2007 614 1-2 3 15
39. Rossi D. J., Bryder D., Seita J., Nussenzweig A., Hoeijmakers J., Weissman I. L., Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age Nature 2007 447 7145 725 729
40. Nijnik A., Woodbine L., Marchetti C., DNA repair is limiting for haematopoietic stem cells during ageing Nature 2007 447 7145 686 690
41. Hildrestrand G. A., Duggal S., Bjrs M., Luna L., Brinchmann J. E., Modulation of DNA glycosylase activities in mesenchymal stem cells Experimental Cell Research 2009 315 15 2558 2567
42. Madhavan L., Ourednik V., Ourednik J., Increased vigilance of antioxidant mechanisms in neural stem cells potentiates their capability to resist oxidative stress Stem Cells 2006 24 9 2110 2119
43. + cells correlates with malignancy of gliomas Molecular and Cellular Neuroscience 2010 43 1 51 59
44. Zeppernick F., Ahmadi R., Campos B., Stem cell marker CD133 affects clinical outcome in glioma patients Clinical Cancer Research 2008 14 1 123 129
45. Rebetz J., Tian D., Persson A., Glial progenitor-like phenotype in low-grade glioma and enhanced CD133-expression and neuronal lineage differentiation potential in high-grade glioma PLoS ONE 2008 3 4, article e1936
46. Gnther H. S., Schmidt N. O., Phillips H. S., Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria Oncogene 2008 27 20 2897 2909
47. Yao J., Zhang T., Ren J., Yu M., Wu G., Effect of CD133/prominin-1 antisense oligodeoxynucleotide on in vitro growth characteristics of Huh-7 human hepatocarcinoma cells and U251 human glioma cells Oncology Reports 2009 22 4 781 787
48. Piccirillo S. G. M., Combi R., Cajola L., Distinct pools of cancer stem-like cells coexist within human glioblastomas and display different tumorigenicity and independent genomic evolution Oncogene 2009 28 15 1807 1811
49. Murat A., Migliavacca E., Gorlia T., Stem cell-related self-renewal signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma Journal of Clinical Oncology 2008 26 18 3015 3024
50. Ma Y.-H., Mentlein R., Knerlich F., Kruse M.-L., Mehdorn H. M., Held-Feindt J., Expression of stem cell markers in human astrocytomas of different WHO grades Journal of Neuro-Oncology 2008 86 1 31 45
51. Kong D.-S., Kim M. H., Park W.-Y., The progression of gliomas is associated with cancer stem cell phenotype Oncology Reports 2008 19 3 639 643
52. Laks D. R., Masterman-Smith M., Visnyei K., Neurosphere formation is an independent predictor of clinical outcome in malignant glioma Stem Cells 2009 27 4 980 987
53. Nishide K., Nakatani Y., Kiyonari H., Kondo T., Glioblastoma formation from cell population depleted of prominin1-expressing cells PLoS ONE 2009 4 8, article e6869
54. Shen G., Shen F., Shi Z., Identification of cancer stem-like cells in the C6 glioma cell line and the limitation of current identification methods In Vitro Cellular Developmental Biology Animal 2008 44 7 280 289
55. + and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas International Journal of Cancer 2009 125 1 15 22
56. Cho R. W., Clarke M. F., Recent advances in cancer stem cells Current Opinion in Genetics and Development 2008 18 1 48 53
57. Dirks P. B., Brain tumor stem cells: bringing order to the chaos of brain cancer Journal of Clinical Oncology 2008 26 17 2916 2924
58. Regenbrecht C. R. A., Lehrach H., Adjaye J., Stemming cancer: functional genomics of cancer stem cells in solid tumors Stem Cell Reviews 2008 4 4 319 328
59. Zhou J., Zhang Y., Cancer stem cells: models, mechanisms and implications for improved treatment Cell Cycle 2008 7 10 1360 1370
60. Wen P. Y., Kesari S., Malignant gliomas in adults The New England Journal of Medicine 2008 359 5 492 507
61. Kanu O. O., Mehta A., Di C., Glioblastoma multiforme: a review of therapeutic targets Expert Opinion on Therapeutic Targets 2009 13 6 701 718
62. Casartelli G., Dorcaratto A., Ravetti J. L., Survival of high grade glioma patients depends on their age at diagnosis Cancer Biology and Therapy 2009 8 18 1719 1721
63. Lefranc F., Rynkowski M., DeWitte O., Kiss R., Present and potential future adjuvant issues in high-grade astrocytic glioma treatment Advances and Technical Standards in Neurosurgery 2009 34 3 35
64. Lafay-Cousin L., Strother D., Current treatment approaches for infants with malignant central nervous system tumors Oncologist 2009 14 4 433 444
65. Cayre M., Canoll P., Goldman J. E., Cell migration in the normal and pathological postnatal mammalian brain Progress in Neurobiology 2009 88 1 41 63
66. Abel T. W., Clark C., Bierie B., GFAP-Cre-mediated activation of oncogenic K-ras results in expansion of the subventricular zone and infiltrating glioma Molecular Cancer Research 2009 7 5 645 653
67. Lindberg N., Kastemar M., Olofsson T., Smits A., Uhrbom L., Oligodendrocyte progenitor cells can act as cell of origin for experimental glioma Oncogene 2009 28 23 2266 2275
68. Appolloni I., Calzolari F., Tutucci E., PDGF-B induces a homogeneous class of oligodendrogliomas from embryonic neural progenitors International Journal of Cancer 2009 124 10 2251 2259
69. Stiles C. D., Rowitch D. H., Glioma stem cells: a midterm exam Neuron 2008 58 6 832 846
70. Park D. M., Rich J. N., Biology of glioma cancer stem cells Molecules and Cells 2009 28 1 7 12
71. Dufour C., Cadusseau J., Varlet P., Astrocytes reverted to a neural progenitor-like state with transforming growth factor alpha are sensitized to cancerous transformation Stem Cells 2009 27 10 2373 2382
72. Rubin L. L., Stem cells and drug discovery: the beginning of a new era? Cell 2008 132 4 549 552
73. Ischenko I., Seeliger H., Schaffer M., Jauch K.-W., Bruns C. J., Cancer stem cells: how can we target them? Current Medicinal Chemistry 2008 15 30 3171 3184
74. Li. Z., Wang H., Eyler C. E., Hjelmeland A. B., Rich J. N., Turning cancer stem cells inside out: an exploration of glioma stem cells signalling pathways Journal of Biological Chemistry 2009 284 25 16705 16709
75. Fael Al-Mayhani T. M., Ball S. L. R., Zhao J.-W., An efficient method for derivation and propagation of glioblastoma cell lines that conserves the molecular profile of their original tumours Journal of Neuroscience Methods 2009 176 2 192 199
76. Pollard S. M., Yoshikawa K., Clarke I. D., Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens Cell Stem Cell 2009 4 6 568 580
77. Ropolo M., Daga A., Griffero F., Comparative analysis of DNA repair in stem and nonstem glioma cell cultures Molecular Cancer Research 2009 7 3 383 392
78. Clment V., Dutoit V., Marino D., Dietrich P.-Y., Radovanovic I., Limits of CD133 as a marker of glioma self-renewing cells International Journal of Cancer 2009 125 1 244 248
79. Bidlingmaier S., Zhu X., Liu B., The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells Journal of Molecular Medicine 2008 86 9 1025 1032
80. Zhao Y., Huang Q., Zhang T., Ultrastructural studies of glioma stem cells/progenitor cells Ultrastructural Pathology 2008 32 6 241 245
81. Borovski T., Vermeulen L., Sprick M. R., Medema J. P., One renegade cancer stem cell? Cell Cycle 2009 8 6 803 808
82. Frosina G., DNA repair and resistance of gliomas to chemotherapy and radiotherapy Molecular Cancer Research 2009 7 7 989 999
83. Dirks P. B., Cancer: stem cells and brain tumours Nature 2006 444 7120 687 688
84. Medrano S., Burns-Cusato M., Atienza M. B., Rahimi D., Scrable H., Regenerative capacity of neural precursors in the adult mammalian brain is under the control of p53 Neurobiology of Aging 2009 30 3 483 497
85. Meletis K., Wirta V., Hede S.-M., Nistr M., Lundeberg J., Frisn J., p53 suppresses the self-renewal of adult neural stem cells Development 2006 133 2 363 369
86. Hulleman E., Helin K., Molecular mechanisms in gliomagenesis Advances in Cancer Research 2005 94 1 1 27
87. Boyer M. J., Cheng T., The CDK inhibitors: potential targets for therapeutic stem cell manipulations? Gene Therapy 2008 15 2 117 125
88. Jackson E. L., Alvarez-Buylla A., Characterization of adult neural stem cells and their relation to brain tumors Cells Tissues Organs 2008 188 1-2 212 224
89. Lee J.-S., Gil J.-E., Kim J.-H., Brain cancer stem-like cell genesis from p53-deficient mouse astrocytes by oncogenic Ras Biochemical and Biophysical Research Communications 2008 365 3 496 502
90. Cai C., Thorne J., Grabel L., Hedgehog serves as a mitogen and survival factor during embryonic stem cell neurogenesis Stem Cells 2008 26 5 1097 1108
91. Galvin K. E., Ye H., Erstad D. J., Feddersen R., Wetmore C., Gli1 induces G2/M arrest and apoptosis in hippocampal but not tumor-derived neural stem cells Stem Cells 2008 26 4 1027 1036
92. Clark P. A., Treisman D. M., Ebben J., Kuo J. S., Developmental signaling pathways in brain tumor-derived stem-like cells Developmental Dynamics 2007 236 12 3297 3308
93. Yao X.-H., Ping Y.-F., Chen J.-H., Glioblastoma stem cells produce vascular endothelial growth factor by activation of a G-protein coupled formylpeptide receptor FPR Journal of Pathology 2008 215 4 369 376
94. Knizetova P., Darling J. L., Bartek J., Vascular endothelial growth factor in astroglioma stem cell biology and response to therapy Journal of Cellular and Molecular Medicine 2008 12 1 111 125
95. Wong E. T., Brem S., Antiangiogenesis treatment for glioblastoma multiforme: challenges and opportunities The Journal of the National Comprehensive Cancer Network 2008 6 5 515 522
96. Bleau A. M., Huse J. T., Holland E. C., The ABCG2 resistance network of glioblastoma Cell Cycle 2009 8 18 2936 2944
97. Johannessen T.-C. A., Bjerkvig R., Tysnes B. B., DNA repair and cancer stem-like cellspotential partners in glioma drug resistance? Cancer Treatment Reviews 2008 34 6 558 567
98. Roth R. B., Samson L. D., 3-methyladenine DNA glycosylase-deficient Aag null mice display unexpected bone marrow alkylation resistance Cancer Research 2002 62 3 656 660
99. Hambardzumyan D., Squatrito M., Carbajal E., Holland E. C., Glioma formation, cancer stem cells, and Akt signaling Stem Cell Reviews 2008 4 3 203 210
100. Kwon C.-H., Zhao D., Chen J., Pten haploinsufficiency accelerates formation of high-grade astrocytomas Cancer Research 2008 68 9 3286 3294
101. Eyler C. E., Foo W.-C., LaFiura K. M., McLendon R. E., Hjelmeland A. B., Rich J. N., Brain cancer stem cells display preferential sensitivity to Akt inhibition Stem Cells 2008 26 12 3027 3036
102. Westhoff M.-A., Kandenwein J. A., Karl S., The pyridinylfuranopyrimidine inhibitor, PI-103, chemosensitizes glioblastoma cells for apoptosis by inhibiting DNA repair Oncogene 2009 28 40 3586 3596
103. Kao G. D., Jiang Z., Fernandes A. M., Gupta A. K., Maity A., Inhibition of phosphatidylinositol-3-OH kinase/Akt signaling impairs DNA repair in glioblastoma cells following ionizing radiation Journal of Biological Chemistry 2007 282 29 21206 21212
104. Bao S., Wu Q., McLendon R. E., Glioma stem cells promote radioresistance by preferential activation of the DNA damage response Nature 2006 444 7120 756 760
105. Rich J. N., Cancer stem cells in radiation resistance Cancer Research 2007 67 19 8980 8984
106. Wang X., Lui V. C. H., Poon R. T. P., Lu P., Poon R. Y. C., DNA damage mediated s and G2 checkpoints in human embryonal carcinoma cells Stem Cells 2009 27 3 568 576
107. Kato T., Kanemura Y., Shiraishi K., Miyake J., Kodama S., Hara M., Early response of neural stem/progenitor cells after X-ray irradiation in vitro NeuroReport 2007 18 9 895 900
108. Beier D., Rhrl S., Pillai D. R., Temozolomide preferentially depletes cancer stem cells in glioblastoma Cancer Research 2008 68 14 5706 5715
109. Viale A., De Franco F., Orleth A., Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells Nature 2009 457 7225 51 56
110. Cimprich K. A., Cortez D., ATR: an essential regulator of genome integrity Nature Reviews Molecular Cell Biology 2008 9 8 616 627
111. Reinhardt H. C., Yaffe M. B., Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2 Current Opinion in Cell Biology 2009 21 2 245 255
112. Enders G. H., Expanded roles for Chk1 in genome maintenance Journal of Biological Chemistry 2008 283 26 17749 17752
113. Bucher N., Britten C. D., G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer British Journal of Cancer 2008 98 3 523 528
114. Zabludoff S. D., Deng C., Grondine M. R., AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies Molecular Cancer Therapeutics 2008 7 9 2955 2966
115. Rainey M. D., Charlton M. E., Stanton R. V., Kastan M. B., Transient inhibition of ATM kinase is sufficient to enhance cellular sensitivity to ionizing radiation Cancer Research 2008 68 18 7466 7474